Zydus Lifesciences

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue2,6942,4783,6944,2672,947
Expenses1,7261,9042,0002,0331,908
EBITDA1,184805.901,9302,4801,269
EBIT1,059678.201,7912,3491,135
Profit Before Tax968.10574.301,6852,2341,039
Net Profit805.00450.401,4051,701789.80
Financial Ratios
Operating Profit Margin57.75%36.22%60.57%61.44%50.51%
Net Profit Margin39.27%20.24%44.50%42.15%31.44%
Earning Per Share (Diluted)7.964.4513.8916.907.85
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ